Use of phenylpropanolamine to reduce nicotine cessation induced weight gain in rats

Suzan E. Winders, Thane Dykstra, Mathilda Coday, John C. Amos, Mary R. Wilson, David R. Wilkins

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The present study was conducted to determine if phenylpropanolamine (PPA) administered during the first week of nicotine termination could reduce or eliminate the body weight rebound which accompanies nicotine cessation. Sprague-Dawley rats were administered nicotine for 2 weeks after which they received either PPA or saline for 1 week. Control animals received saline during both drug periods. Body weight, food consumption, and water consumption were measured daily before drug, during nicotine and PPA administration, and for 14 days after PPA administration. In contrast to animals receiving saline upon termination of nicotine, animals receiving PPA did not gain weight at an accelerated rate. Termination of PPA did not result in a body weight rebound. To the extent that these results generalize to humans, they suggest that PPA could be used to reduce or eliminate postcessation weight gain in smokers who stop smoking.

Original languageEnglish (US)
Pages (from-to)501-506
Number of pages6
JournalPsychopharmacology
Volume108
Issue number4
DOIs
StatePublished - Sep 1 1992

Fingerprint

Phenylpropanolamine
Nicotine
Weight Gain
Body Weight
Pharmaceutical Preparations
Drinking
Sprague Dawley Rats
Smoking
Food

All Science Journal Classification (ASJC) codes

  • Pharmacology

Cite this

Winders, S. E., Dykstra, T., Coday, M., Amos, J. C., Wilson, M. R., & Wilkins, D. R. (1992). Use of phenylpropanolamine to reduce nicotine cessation induced weight gain in rats. Psychopharmacology, 108(4), 501-506. https://doi.org/10.1007/BF02247428

Use of phenylpropanolamine to reduce nicotine cessation induced weight gain in rats. / Winders, Suzan E.; Dykstra, Thane; Coday, Mathilda; Amos, John C.; Wilson, Mary R.; Wilkins, David R.

In: Psychopharmacology, Vol. 108, No. 4, 01.09.1992, p. 501-506.

Research output: Contribution to journalArticle

Winders, SE, Dykstra, T, Coday, M, Amos, JC, Wilson, MR & Wilkins, DR 1992, 'Use of phenylpropanolamine to reduce nicotine cessation induced weight gain in rats', Psychopharmacology, vol. 108, no. 4, pp. 501-506. https://doi.org/10.1007/BF02247428
Winders, Suzan E. ; Dykstra, Thane ; Coday, Mathilda ; Amos, John C. ; Wilson, Mary R. ; Wilkins, David R. / Use of phenylpropanolamine to reduce nicotine cessation induced weight gain in rats. In: Psychopharmacology. 1992 ; Vol. 108, No. 4. pp. 501-506.
@article{d46af5041a4344f3b12839c8a101dcbb,
title = "Use of phenylpropanolamine to reduce nicotine cessation induced weight gain in rats",
abstract = "The present study was conducted to determine if phenylpropanolamine (PPA) administered during the first week of nicotine termination could reduce or eliminate the body weight rebound which accompanies nicotine cessation. Sprague-Dawley rats were administered nicotine for 2 weeks after which they received either PPA or saline for 1 week. Control animals received saline during both drug periods. Body weight, food consumption, and water consumption were measured daily before drug, during nicotine and PPA administration, and for 14 days after PPA administration. In contrast to animals receiving saline upon termination of nicotine, animals receiving PPA did not gain weight at an accelerated rate. Termination of PPA did not result in a body weight rebound. To the extent that these results generalize to humans, they suggest that PPA could be used to reduce or eliminate postcessation weight gain in smokers who stop smoking.",
author = "Winders, {Suzan E.} and Thane Dykstra and Mathilda Coday and Amos, {John C.} and Wilson, {Mary R.} and Wilkins, {David R.}",
year = "1992",
month = "9",
day = "1",
doi = "10.1007/BF02247428",
language = "English (US)",
volume = "108",
pages = "501--506",
journal = "Psychopharmacology",
issn = "0033-3158",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Use of phenylpropanolamine to reduce nicotine cessation induced weight gain in rats

AU - Winders, Suzan E.

AU - Dykstra, Thane

AU - Coday, Mathilda

AU - Amos, John C.

AU - Wilson, Mary R.

AU - Wilkins, David R.

PY - 1992/9/1

Y1 - 1992/9/1

N2 - The present study was conducted to determine if phenylpropanolamine (PPA) administered during the first week of nicotine termination could reduce or eliminate the body weight rebound which accompanies nicotine cessation. Sprague-Dawley rats were administered nicotine for 2 weeks after which they received either PPA or saline for 1 week. Control animals received saline during both drug periods. Body weight, food consumption, and water consumption were measured daily before drug, during nicotine and PPA administration, and for 14 days after PPA administration. In contrast to animals receiving saline upon termination of nicotine, animals receiving PPA did not gain weight at an accelerated rate. Termination of PPA did not result in a body weight rebound. To the extent that these results generalize to humans, they suggest that PPA could be used to reduce or eliminate postcessation weight gain in smokers who stop smoking.

AB - The present study was conducted to determine if phenylpropanolamine (PPA) administered during the first week of nicotine termination could reduce or eliminate the body weight rebound which accompanies nicotine cessation. Sprague-Dawley rats were administered nicotine for 2 weeks after which they received either PPA or saline for 1 week. Control animals received saline during both drug periods. Body weight, food consumption, and water consumption were measured daily before drug, during nicotine and PPA administration, and for 14 days after PPA administration. In contrast to animals receiving saline upon termination of nicotine, animals receiving PPA did not gain weight at an accelerated rate. Termination of PPA did not result in a body weight rebound. To the extent that these results generalize to humans, they suggest that PPA could be used to reduce or eliminate postcessation weight gain in smokers who stop smoking.

UR - http://www.scopus.com/inward/record.url?scp=0026713470&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026713470&partnerID=8YFLogxK

U2 - 10.1007/BF02247428

DO - 10.1007/BF02247428

M3 - Article

VL - 108

SP - 501

EP - 506

JO - Psychopharmacology

JF - Psychopharmacology

SN - 0033-3158

IS - 4

ER -